Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.
About
Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform to treat chronic inflammatory disorders by stimulating the spleen-brain axis, known as the cholinergic anti-inflammatory pathway. Their patented BROAD-BEAM ULTRASOUND STIMULATION technology activates nerves to release neurotransmitters that signal the immune system to restore balance and calm inflammation. This platform aims to provide therapeutic benefits for conditions such as Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, and Multiple Sclerosis.
Tags
Total Employees
10
Current headcount
Score Breakdown
10Traction
44Team
60Visibility
9Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Surf Therapeutics do?
Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform to treat chronic inflammatory disorders by stimulating the spleen-brain axis, known as the cholinergic anti-inflammatory pathway. Their patented BROAD-BEAM ULTRASOUND STIMULATION technology activates nerves to release neurotransmitters that signal the immune system to restore balance and calm inflammation. This platform aims to provide therapeutic benefits for conditions such as Rheumatoid Arthritis, Psoriasis/Pso…
How much funding has Surf Therapeutics raised?
Surf Therapeutics has raised a total of $6M in funding. The most recent round on record is Seed.
Where is Surf Therapeutics headquartered?
Surf Therapeutics is headquartered in Austin, United States.
When was Surf Therapeutics founded?
Surf Therapeutics was founded in 2022.
What industry does Surf Therapeutics operate in?
Surf Therapeutics operates in Biotechnology, Medical Devices, HealthTech, Neurology, Life Sciences.
How many employees does Surf Therapeutics have?
Surf Therapeutics has approximately 10 people on record.